(2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid

C56H102N20O14 — CID 139493770

IUPAC(2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid
SMILESNC(N)=NCCC[C@@H]1NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCNC(=O)CCC(NC(=O)CCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)CC[C@@H](C(=O)O)NC1=O
InChIInChI=1S/C56H102N20O14/c57-53(58)66-31-15-20-36-47(83)73-37(21-16-32-67-54(59)60)48(84)74-38(22-17-33-68-55(61)62)49(85)75-39(23-18-34-69-56(63)64)50(86)76-41(52(89)90)27-29-44(79)70-35(46(82)72-36)19-13-14-30-65-42(77)28-26-40(51(87)88)71-43(78)24-11-9-7-5-3-1-2-4-6-8-10-12-25-45(80)81/h35-41H,1-34H2,(H,65,77)(H,70,79)(H,71,78)(H,72,82)(H,73,83)(H,74,84)(H,75,85)(H,76,86)(H,80,81)(H,87,88)(H,89,90)(H4,57,58,66)(H4,59,60,67)(H4,61,62,68)(H4,63,64,69)/t35-,36-,37-,38-,39-,40?,41-/m0/s1
InChIKeyIIBQVDJBJPQNMI-FMSMCWGMSA-N
MW1279.56 g/mol
LogP-2.83
Rot. Bonds42

About (2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid

(2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid (PubChem CID 139493770) has the molecular formula C56H102N20O14 and a molecular weight of 1279.56 g/mol. Its IUPAC name is (2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid.

Molecular Properties

Compound Name(2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid
PubChem CID139493770
Molecular FormulaC56H102N20O14
Molecular Weight1279.56 g/mol
Exact Mass1278.79
IUPAC Name(2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid
SMILESNC(N)=NCCC[C@@H]1NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCNC(=O)CCC(NC(=O)CCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)CC[C@@H](C(=O)O)NC1=O
InChIInChI=1S/C56H102N20O14/c57-53(58)66-31-15-20-36-47(83)73-37(21-16-32-67-54(59)60)48(84)74-38(22-17-33-68-55(61)62)49(85)75-39(23-18-34-69-56(63)64)50(86)76-41(52(89)90)27-29-44(79)70-35(46(82)72-36)19-13-14-30-65-42(77)28-26-40(51(87)88)71-43(78)24-11-9-7-5-3-1-2-4-6-8-10-12-25-45(80)81/h35-41H,1-34H2,(H,65,77)(H,70,79)(H,71,78)(H,72,82)(H,73,83)(H,74,84)(H,75,85)(H,76,86)(H,80,81)(H,87,88)(H,89,90)(H4,57,58,66)(H4,59,60,67)(H4,61,62,68)(H4,63,64,69)/t35-,36-,37-,38-,39-,40?,41-/m0/s1
InChIKeyIIBQVDJBJPQNMI-FMSMCWGMSA-N
XLogP-2.83
TPSA602.30 Ų
H-Bond Donors19
H-Bond Acceptors15
Rotatable Bonds42
Heavy Atoms90
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001279.56
LogP ≤ 5-2.83
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze (2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid?
The IUPAC name of (2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid (CID 139493770) is (2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid.
What is the SMILES notation for (2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid?
The canonical SMILES for (2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid is NC(N)=NCCC[C@@H]1NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCNC(=O)CCC(NC(=O)CCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)CC[C@@H](C(=O)O)NC1=O.
What is the InChIKey of (2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid?
The InChIKey is IIBQVDJBJPQNMI-FMSMCWGMSA-N. The full InChI is InChI=1S/C56H102N20O14/c57-53(58)66-31-15-20-36-47(83)73-37(21-16-32-67-54(59)60)48(84)74-38(22-17-33-68-55(61)62)49(85)75-39(23-18-34-69-56(63)64)50(86)76-41(52(89)90)27-29-44(79)70-35(46(82)72-36)19-13-14-30-65-42(77)28-26-40(51(87)88)71-43(78)24-11-9-7-5-3-1-2-4-6-8-10-12-25-45(80)81/h35-41H,1-34H2,(H,65,77)(H,70,79)(H,71,78)(H,72,82)(H,73,83)(H,74,84)(H,75,85)(H,76,86)(H,80,81)(H,87,88)(H,89,90)(H4,57,58,66)(H4,59,60,67)(H4,61,62,68)(H4,63,64,69)/t35-,36-,37-,38-,39-,40?,41-/m0/s1.
What are the key properties of (2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid?
(2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid has a molecular weight of 1279.56 g/mol, XLogP of -2.83, 42 rotatable bonds, 19 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,5S,8S,11S,14S,17S)-2-[4-[[4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butyl]-5,8,11,14-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,20-hexaoxo-1,4,7,10,13,16-hexazacycloicosane-17-carboxylic acid is sourced from PubChem (CID 139493770), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).